Skip to main content

X-LINKED AGAMMAGLOBULINEMIA

Tracking # 20-812041

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

X-LINKED AGAMMAGLOBULINEMIA OR XLA IS A PRIMARY IMMUNODEFICIENCY DISORDER THAT PREVENTS AFFECTED INDIVIDUALS FROM MAKING ANTIBODIES AND REQUIRES THEM TO RELY ON LIFELONG IMMUNOGLOBULIN REPLACEMENT THERAPY FOR SURVIVAL. WITHOUT IMMUNOGLOBULINS (OR ANTIBODIES), XLA PATIENTS ARE RENDERED VULNERABLE TO INVASIVE INFECTIONS. HOSPITALIZATION FOR BACTERIAL PNEUMONIA, REQUIRING INTRAVENOUS ANTIBIOTICS FOR RESOLUTION, IS USUALLY WHAT PROMPTS THE DIAGNOSTIC WORK-UP FOR PRIMARY IMMUNODEFICIENCY. THIS ACTIVITY REVIEWS THE PATHOPHYSIOLOGY OF XLA AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN ITS MANAGEMENT.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I